研判2025!中国血管内超声(IVUS)系统行业市场政策、产业链图谱、采购规模、竞争格局及发展趋势分析:进口产品市场占有率高达80.62%[图]

Core Insights - The incidence of cardiovascular diseases in China is rising due to an aging population, leading to increased demand for intravascular ultrasound (IVUS) systems, which are recognized for their clinical value in guiding interventions and reducing postoperative complications [1][8] - The IVUS system market is experiencing significant growth, with procurement volumes and values increasing substantially year-on-year, indicating a shift towards routine use in clinical settings [1][8] Market Overview - The IVUS system is an interventional imaging technology that provides precise imaging of vascular structures using a specially designed catheter with a miniature ultrasound probe [2] - The market for IVUS systems is supported by various government policies aimed at enhancing the medical device industry, ensuring product quality, and promoting patient safety [5][6] Industry Chain - The IVUS industry chain consists of upstream core component suppliers, midstream equipment R&D and manufacturing, and downstream application markets, with hospitals being the primary demand source [6][7] - The demand for IVUS systems is driven by the increasing prevalence of coronary artery disease, which is the leading cause of death in China [7] Competitive Landscape - The IVUS market in China is characterized by a competition between foreign and domestic companies, with foreign firms like Boston Scientific and Philips holding a significant market share, particularly in the high-end segment [9] - Domestic companies such as Kaili Medical and North Chip are making strides in the market, with increasing market shares due to ongoing R&D efforts and technological advancements [10][12] Development Trends - Future policies are expected to support the IVUS industry through funding, tax incentives, and streamlined approval processes, which will encourage innovation and market entry for domestic products [13] - The domestic IVUS market is anticipated to grow as local companies improve their technology and product offerings, potentially disrupting the current foreign-dominated market structure [13]

研判2025!中国血管内超声(IVUS)系统行业市场政策、产业链图谱、采购规模、竞争格局及发展趋势分析:进口产品市场占有率高达80.62%[图] - Reportify